RIGL Rigel Pharmaceuticals, Inc. logo

RIGL Rigel Pharmaceuticals, Inc.

Healthcare
$29.01-0.62%ClosedMarket Cap: $536.7M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

191

13F Shares

16,095,429

Ownership %

89.2%

New Positions

46

Increased Positions

111

Closed Positions

26

Reduced Positions

62

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
FDLSInspire Fidelis Multi Factor ETF64,2421.01%
IDNAiShares Genomics Immunology and Healthcare ETF28,5170.51%
JSMLJanus Henderson Small Cap Growth Alpha ETF37,6050.37%
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETF95,7770.32%
SBIOALPS Medical Breakthroughs ETF15,0360.32%
XBI708,7760.26%
BFORBarron's 400SM ETF19,0840.25%
LABUDirexion Daily S&P Biotech Bull 3X ETF35,4490.19%
JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF29,9230.15%
SLTPacer Salt High truBeta US Market ETF64,6240.14%
LSLTPacer Salt Low truBeta US Market ETF64,6240.14%
VIRS64,6240.14%
VETS64,6240.14%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF64,6240.14%
VFMO37,2660.13%
AVUVX36,7780.13%
IJE45,0950.10%
IWCiShares Micro-Cap ETF45,0950.10%
EESWisdomTree U.S. SmallCap Fund18,8450.08%
PSCPrincipal U.S. Small-Cap Multi-Factor ETF47,2830.07%